Penn engineers turn toxic fungus into anti-cancer drug
Penn-led researchers have isolated a new class of molecules from Aspergillus flavus, a toxic crop fungus, and modified it into a promising cancer-killing compound.
2 min. read
Researchers at Penn’s School of Engineering and Applied Science have turned a deadly fungus into a potent cancer-fighting compound. After isolating a new class of molecules from Aspergillus flavus, a toxic crop fungus linked to deaths in the excavations of ancient tombs, the researchers modified the chemicals and tested them against leukemia cells. The result? A promising cancer-killing compound that rivals FDA-approved drugs and opens up new frontiers in the discovery of more fungal medicines.
First author Qiuyue Nie (left) and coauthor Maria Zotova purify samples of the fungus.
(Image: Bella Ciervo)
“Fungi gave us penicillin,” says Sherry Gao, Presidential Penn Compact Associate Professor in Chemical and Biomolecular Engineering (CBE) and in Bioengineering (BE) and senior author of the paper, published in Nature Chemical Biology. “These results show that many more medicines derived from natural products remain to be found.”
The treatment belongs to a class of ribosomally synthesized and post-translationally modified peptides (RiPPs). This name reveals how these therapeutic compounds are produced.
First, they’re originated by the ribosome, a small cellular structure that builds proteins. Then, researchers modify them in labs to enhance cancer-killing properties.
While thousands of RiPPs have been identified in bacteria, only a handful have been found in fungi—making this area of research ripe for groundbreaking discovery.
“The synthesis of these compounds is complicated,” says Qiuyue Nie, a postdoctoral fellow in CBE and the paper’s first author. “But that’s also what gives them this remarkable bioactivity.”
To find more fungal RiPPs, researchers scanned a dozen strains of Aspergillus, which studies suggest may contain more of these anti-cancer compounds. When the researchers compared the chemicals produced by these strains with known RiPP building blocks, they found A. flavus to be a promising candidate for further study.
Genetic analysis unveiled a certain protein in A. flavus to be a source of fungal RiPPs. When the researchers shut off the genes that create this protein, the chemical markers signaling the presence of RiPPs also disappeared. This novel approach—combining metabolic and genetic information—pinpointed the source of fungal RiPPs in A. flavus and could be used to find more fungal RiPPs in the future.
People living on small islands and territories face mounting climate impacts, but little is known about their stance on the issue. Research from a team including Parrish Bergquist, assistant professor of political science, aims to fill those gaps.
Penn researchers developed a system that allows light to be guided through a tiny crystal, undeterred by bumps, bends, and back-reflections. Their findings pave the way for robust, controllable light-based chips, smarter routing for data links, and more stable lasers.
A West Philadelphia High School student practices the drum as part of a July summer program in partnership with the Netter Center for Community Partnerships and nonprofit Musicopia.
A summer of student enrichment, from big ideas to bold beats
The Netter Center for Community Partnerships finished its summer of programming for West Philadelphia students, impacting 640 students and six University-Assisted Community Schools.
